<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">Coronary heart disease</z:e> (CHD) that is due to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> is associated with low-grade systemic <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Congestive <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> and <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> that are responsible for mortality in CHD can be suppressed by appropriate vagal stimulation that is anti-inflammatory in nature </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="9" ids="15355">Acetylcholine</z:chebi>, the principal vagal neurotransmitter, is a potent anti-inflammatory molecule </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="7" ids="26208">Polyunsaturated fatty acids</z:chebi> (PUFAs) augment <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> release, while <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> can enhance the formation of prostacyclin, <z:chebi fb="0" ids="6497">lipoxins</z:chebi>, resolvins, protectins and maresins from PUFAs, which are anti-inflammatory and anti-arrhythmic molecules </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, plasma and tissue levels of PUFAs are low in those with CHD and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Hence, vagal nerve stimulation is beneficial in the prevention of CHD and <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, measurement of <z:chebi fb="2" ids="33567">catecholamines</z:chebi>, <z:chebi fb="9" ids="15355">acetylcholine</z:chebi>, various PUFAs, and their products <z:chebi fb="0" ids="6497">lipoxins</z:chebi>, resolvins, protectins and maresins in the plasma and peripheral leukocytes, and vagal tone by heart rate variation could be useful in the prediction, prevention and management of CHD and <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
</text></document>